{"id":"NCT03663582","sponsor":"Shire","briefTitle":"Study of Teduglutide in Japanese Participants With Short Bowel Syndrome","officialTitle":"A 24-Week Safety, Efficacy, Pharmacokinetic Study of Teduglutide in Japanese Subjects With Short Bowel Syndrome Who Are Dependent on Parenteral Support","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-07-06","primaryCompletion":"2019-08-06","completion":"2019-08-06","firstPosted":"2018-09-10","resultsPosted":"2020-08-04","lastUpdate":"2020-08-04"},"enrollment":7,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Short Bowel Syndrome"],"interventions":[{"type":"DRUG","name":"Teduglutide","otherNames":[]},{"type":"DEVICE","name":"Syringe","otherNames":[]},{"type":"DEVICE","name":"Needle","otherNames":[]},{"type":"DEVICE","name":"Vial Adapter for Device","otherNames":[]}],"arms":[{"label":"Teduglutide 0.05 mg","type":"EXPERIMENTAL"}],"summary":"The objectives of this clinical study are to evaluate the safety, efficacy, and pharmacokinetics (PK) of teduglutide in Japanese participants with short bowel syndrome (SBS) who are dependent on parenteral nutrition/intravenous (PN/IV) over a 24-week treatment period.","primaryOutcome":{"measure":"Change From Baseline in Weekly Parenteral Support (PS) Volume at End of Treatment/Early Termination (EOT/ET)","timeFrame":"Baseline, EOT/ET (up to Week 28)","effectByArm":[{"arm":"Teduglutide","deltaMin":-2.92,"sd":3.463}],"pValues":[]},"eligibility":{"minAge":"16 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":5,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":7},"commonTop":["Abdominal distension","Injection site reaction","Pyrexia","Nasopharyngitis","Anaemia"]}}